JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265351

Human LAMTOR1 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

LAMTOR1 KO cell line available to order. KO validated by Western blot. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and 4 bp insertion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
3 Images
Western blot - Human LAMTOR1 knockout HeLa cell line (AB265351)
  • WB

Lab

Western blot - Human LAMTOR1 knockout HeLa cell line (AB265351)

Lanes 1 - 4 : Merged signal (red and green). Green - ab121157 observed at 18 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55 kDa.

ab121157 was shown to react with LAMTOR1 in wild-type HeLa cells in Western blot with loss of signal observed in LAMTOR1 knockout cell line ab265351 (LAMTOR1 knockout cell lysate ab258938). Wild-type HeLa and LAMTOR1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab121157 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4 °C at 0.04 µg/ml and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.

Lanes 1 - 4:

Western blot - Anti-LAMTOR1 antibody (<a href='/en-us/products/primary-antibodies/lamtor1-antibody-ab121157'>ab121157</a>) at 0.04 µg/mL

Lanes 1 - 4:

Western blot - Anti-LAMTOR1 antibody (<a href='/en-us/products/primary-antibodies/lamtor1-antibody-ab229760'>ab229760</a>) at 1/500 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

LAMTOR1 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human LAMTOR1 knockout HeLa cell line (ab265351)

Lane 3:

PANC-1 cell lysate at 20 µg

Lane 4:

U-2 OS cell lysate at 20 µg

Predicted band size: 18 kDa

Observed band size: 18 kDa

false

Sanger Sequencing - Human LAMTOR1 knockout HeLa cell line (AB265351)
  • Sanger seq

Unknown

Sanger Sequencing - Human LAMTOR1 knockout HeLa cell line (AB265351)

Allele-2 : 4 bp insertion in exon 1.

Sanger Sequencing - Human LAMTOR1 knockout HeLa cell line (AB265351)
  • Sanger seq

Unknown

Sanger Sequencing - Human LAMTOR1 knockout HeLa cell line (AB265351)

Allele-1 : 1 bp deletion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and 4 bp insertion in exon 1

Disease

Adenocarcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265351-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265351-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265351 Human LAMTOR1 knockout HeLa cell line", "number":"AB265351-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265351-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265351 Human LAMTOR1 knockout HeLa cell line", "number":"AB265351-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265351-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265351-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265351 Human LAMTOR1 knockout HeLa cell line", "number":"AB265351-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265351-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265351 Human LAMTOR1 knockout HeLa cell line", "number":"AB265351-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
LAMTOR1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

LAMTOR1 also known as p18 is a protein with a mass of approximately 18 kDa. It functions mechanically as a scaffold protein located on the late endosome/lysosome membrane. The protein's primary role involves recruiting and stabilizing the other members of the Ragulator complex. LAMTOR1 is expressed in various tissues with significant levels in immune and neuronal cells where it supports cellular growth and immune responses.
Biological function summary

LAMTOR1 acts as a part of the highly-conserved Ragulator complex. The Ragulator complex is vital for the activation of the mechanistic target of rapamycin complex 1 (mTORC1) in response to amino acids. LAMTOR1's interaction with other components of the complex such as LAMTOR2 and LAMTOR3 facilitates the localization and activation of mTORC1 on the lysosomal surface. This activation promotes anabolic processes including protein lipid and nucleotide synthesis.

Pathways

LAMTOR1 plays an important role in the mTOR signaling pathway. This pathway regulates cell growth proliferation and metabolism. LAMTOR1's involvement with Rag proteins assists in sensing amino acid levels thereby influencing the mTORC1 pathway activation. Additionally LAMTOR1-related pathways intersect with the AMPK signaling pathway where it functionally interacts with proteins that control cellular energy homeostasis.

LAMTOR1's dysregulation has been associated with conditions like cancer and neurodegenerative disorders. Altered expression of LAMTOR1 can impact mTORC1 signaling leading to uncontrolled cell growth often observed in cancerous cells. In neurodegenerative disorders defects in mTORC1 pathway can cause neuronal cell damage. These conditions link LAMTOR1 to proteins like Rheb and TSC2 which are important for maintaining a balance in these signaling pathways.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com